Risperidone: A Novel Antipsychotic Medication
William M. Land, Carl Salzman
Abstract
William M. Land, Carl Salzman
Abstract
Risperidone appears to be a significant advance in the treatment of schizophrenia. Its effectiveness for other serious psychiatric conditions, such as schizoaffective disorder and manic-depressive illness, has not been systematically studied. Further research is also needed to examine whether risperidone will be beneficial and adequately tolerated in special patient populations, including adolescents, the elderly, and psychiatric patients with concomitant medical illnesses.
OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Risperidone appears to be a significant advance in the treatment of schizophrenia. Its effectiveness for other serious psychiatric conditions, such as schizoaffective disorder and manic-depressive illness, has not been systematically studied. Further research is also needed to examine whether risperidone will be beneficial and adequately tolerated in special patient populations, including adolescents, the elderly, and psychiatric patients with concomitant medical illnesses.
Key concepts: Risperidone, Schizophrenia (object-oriented programming), Psychiatry, Schizoaffective disorder, Concomitant, Antipsychotic, Medicine, Psychosis